Analysts’ Viewpoint on Cell Culture Media, Sera, and Reagents Market Scenario
The global cell culture media, sera, and reagents market is majorly driven by growth and expansion of biotechnology & pharmaceutical companies and academic & research institutes. Ongoing research & development activities in biopharmaceuticals are expected to show profitable revenue opportunities for market players operating in the global cell culture media, sera, and reagents market. The increase in demand for biopharmaceuticals and artificial organs is also driving the expansion of the global market. Applications of biological drugs such as hormones, vaccines, antibodies, etc. are increasing due to the limited applicability of conventional pharmaceuticals for the treatment of various diseases.
Cell culture products increase productivity by lowering manufacturing costs. Cell culture is a process of removing cells from an animal or plant source, and use these cells for creating biosimilar or biologic therapeutics. Due to the increasing demand for biosimilar and biologics products for the treatment of cancer and various other chronic and cardiovascular diseases, cell culture method is found to be effective and efficient in the biopharmaceutical sector.
Biosimilar products have gained tremendous popularity in North America and Europe. There is an increasing demand for cost-effective cell culture products and artificial organs across the globe. Antibiotics and amino acid supplements are the most common cell culture reagents used in developing nations. Moreover, increasing applications of Fetal bovine serum (FBS) in regulating cell membrane permeability is fueling the global market growth.
Stem cell research is one of the key drivers for the global cell culture media, sera, and reagents market. Rise in awareness about the stem cell therapy for the treatment of various diseases is fueling market growth. Hence, there is an increasing demand for contract manufacturing. Rapid expansion of pharmaceutical companies, superior drug development & discovery procedures, increase in the number of clinical research institutes across the globe are some of the factors contributing to the global cell culture media, sera, and reagents market growth. However, high costs, along with the scarcity of suitable infrastructure for R&D is expected to hamper the market growth during the forecast period.
North America is expected to account for a major share of the global cell culture media, sera, and reagents market during the forecast period. The lucrative presence of market players operating in the North America cell culture media, sera, and reagents market is a major factor responsible for the market growth in the region. The North America cell culture media, sera, and reagents market is also driven by the strong support from governments, increasing investments in cell-based research & development, and regulatory approvals for cell culture-based vaccines.
The increase in demand for animal component-free media and automated cell culture systems is expected to create growth opportunities in North America for market players. In addition, the rising prevalence of diseases such as cancer in the region is contributing to the expansion of the market.
Countries in Asia Pacific such as China and India are the fastest growing markets for cell culture media, sera, and reagents in the region. Rapid urbanization and increasing investments in research activities are key factors contributing to the market growth in Asia Pacific. Companies operating in the regional market are expected to witness potential growth opportunities. Technological advancements in healthcare, high biopharmaceutical R&D expenditure, and greater adoption of advanced technologies are also fueling the growth of the market in the region.
The global coronavirus pandemic has created opportunities for manufacturers operating in the global cell culture media, sera, and reagents market. This is due to the increasing demand for vaccines across the globe. The global cell culture media, sera, and reagents market is expected to be driven by rising research-based activities, along with clinical trials of vaccines. The global cell culture media, sera, and reagents market is also fueled by surge in demand for biopharmaceuticals, increase in product development by key market contributors, and development of novel vaccines.
There is an increasing demand for cost-effective, reliable, low-risk, and highly efficient cell culture products such as bioreactors, media, reagents, and sera for the creation of high-yield cell lines. In order to fulfill this demand, many cell culture manufacturers are focusing on increasing the production of innovative products.
|
Attribute |
Detail |
|
Market Size Value in 2020 (Base Year) |
US$ 6.1 Bn |
|
Market Forecast Value in 2031 |
US$ 18.3 Bn |
|
Growth Rate (CAGR) |
10.3% |
|
Forecast Period |
2021 to 2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview. |
|
Format |
Electronic (PDF) |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Cell Culture Media, Sera, and Reagents Market – Segmentation
TMR’s study on the global cell culture media, sera, and reagents market includes information divided into three segments: product, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global cell culture media, sera, and reagents market are discussed in detail.
| Product |
|
| End-user |
|
| Region |
|
Cell culture media, sera, and reagents market is expected to reach the value at US$ 18.3 Bn by the end of 2031
Cell culture media, sera, and reagents market to expand at a CAGR of 10.3% from 2021 to 2031
Cell culture media, sera, and reagents market is driven by rise in demand for biopharmaceuticals
North America is expected to account for a major share of the global cell culture media, sera, and reagents market during the forecast period
Key players operating in the global cell culture media, sera, and reagents market include Thermo Fisher Scientific, Inc., Merck KGaA, Cytiva (Danaher Corporation), Becton, Dickinson and Company
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cell Culture Media, Sera and Reagents Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. COVID-19 Impact Analysis
6. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Media
6.3.1.1. Chemically-defined
6.3.1.2. Classical Media
6.3.1.3. Lysogeny Broth
6.3.1.4. Protein Free
6.3.1.5. Serum Free
6.3.1.6. Specialty Media
6.3.2. Sera
6.3.2.1. Fetal Bovine
6.3.2.2. Newborn Calf
6.3.2.3. Others
6.3.3. Reagents
6.3.3.1. Albumin
6.3.3.1.1. Human Serum Albumin
6.3.3.1.2. Bovine Serum Albumin
6.3.3.1.3. Recombinant Serum Albumin
6.3.3.2. Amino Acids
6.3.3.3. Attached Factors
6.3.3.4. Growth Factors & Cytokines
6.3.3.4.1. Transforming Growth Factor ß1
6.3.3.4.2. Epidermal Growth Factor
6.3.3.4.3. Interleukins & Interferons
6.3.3.4.4. Others
6.3.3.5. Protease Inhibitors
6.3.3.6. Thrombin
6.3.3.7. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Biotechnology & Pharmaceutical Companies
7.3.2. Academic & Research Institutes
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Cell Culture Media, Sera and Reagents Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Cell Culture Media, Sera and Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. Media
9.2.1.1. Chemically-defined
9.2.1.2. Classical Media
9.2.1.3. Lysogeny Broth
9.2.1.4. Protein Free
9.2.1.5. Serum Free
9.2.1.6. Specialty Media
9.2.2. Sera
9.2.2.1. Fetal Bovine
9.2.2.2. Newborn Calf
9.2.2.3. Others
9.2.3. Reagents
9.2.3.1. Albumin
9.2.3.1.1. Human Serum Albumin
9.2.3.1.2. Bovine Serum Albumin
9.2.3.1.3. Recombinant Serum Albumin
9.2.3.2. Amino Acids
9.2.3.3. Attached Factors
9.2.3.4. Growth Factors & Cytokines
9.2.3.4.1. Transforming Growth Factor ß1
9.2.3.4.2. Epidermal Growth Factor
9.2.3.4.3. Interleukins & Interferons
9.2.3.4.4. Others
9.2.3.5. Protease Inhibitors
9.2.3.6. Thrombin
9.2.3.7. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Biotechnology & Pharmaceutical Companies
9.3.2. Academic & Research Institutes
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Cell Culture Media, Sera and Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Media
10.2.1.1. Chemically-defined
10.2.1.2. Classical Media
10.2.1.3. Lysogeny Broth
10.2.1.4. Protein Free
10.2.1.5. Serum Free
10.2.1.6. Specialty Media
10.2.2. Sera
10.2.2.1. Fetal Bovine
10.2.2.2. Newborn Calf
10.2.2.3. Others
10.2.3. Reagents
10.2.3.1. Albumin
10.2.3.1.1. Human Serum Albumin
10.2.3.1.2. Bovine Serum Albumin
10.2.3.1.3. Recombinant Serum Albumin
10.2.3.2. Amino Acids
10.2.3.3. Attached Factors
10.2.3.4. Growth Factors & Cytokines
10.2.3.4.1. Transforming Growth Factor ß1
10.2.3.4.2. Epidermal Growth Factor
10.2.3.4.3. Interleukins & Interferons
10.2.3.4.4. Others
10.2.3.5. Protease Inhibitors
10.2.3.6. Thrombin
10.2.3.7. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Biotechnology & Pharmaceutical Companies
10.3.2. Academic & Research Institutes
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Media
11.2.1.1. Chemically-defined
11.2.1.2. Classical Media
11.2.1.3. Lysogeny Broth
11.2.1.4. Protein Free
11.2.1.5. Serum Free
11.2.1.6. Specialty Media
11.2.2. Sera
11.2.2.1. Fetal Bovine
11.2.2.2. Newborn Calf
11.2.2.3. Others
11.2.3. Reagents
11.2.3.1. Albumin
11.2.3.1.1. Human Serum Albumin
11.2.3.1.2. Bovine Serum Albumin
11.2.3.1.3. Recombinant Serum Albumin
11.2.3.2. Amino Acids
11.2.3.3. Attached Factors
11.2.3.4. Growth Factors & Cytokines
11.2.3.4.1. Transforming Growth Factor ß1
11.2.3.4.2. Epidermal Growth Factor
11.2.3.4.3. Interleukins & Interferons
11.2.3.4.4. Others
11.2.3.5. Protease Inhibitors
11.2.3.6. Thrombin
11.2.3.7. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Biotechnology & Pharmaceutical Companies
11.3.2. Academic & Research Institutes
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of APAC
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Cell Culture Media, Sera and Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Media
12.2.1.1. Chemically-defined
12.2.1.2. Classical Media
12.2.1.3. Lysogeny Broth
12.2.1.4. Protein Free
12.2.1.5. Serum Free
12.2.1.6. Specialty Media
12.2.2. Sera
12.2.2.1. Fetal Bovine
12.2.2.2. Newborn Calf
12.2.2.3. Others
12.2.3. Reagents
12.2.3.1. Albumin
12.2.3.1.1. Human Serum Albumin
12.2.3.1.2. Bovine Serum Albumin
12.2.3.1.3. Recombinant Serum Albumin
12.2.3.2. Amino Acids
12.2.3.3. Attached Factors
12.2.3.4. Growth Factors & Cytokines
12.2.3.4.1. Transforming Growth Factor ß1
12.2.3.4.2. Epidermal Growth Factor
12.2.3.4.3. Interleukins & Interferons
12.2.3.4.4. Others
12.2.3.5. Protease Inhibitors
12.2.3.6. Thrombin
12.2.3.7. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Biotechnology & Pharmaceutical Companies
12.3.2. Academic & Research Institutes
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of LATAM
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Media
13.2.1.1. Chemically-defined
13.2.1.2. Classical Media
13.2.1.3. Lysogeny Broth
13.2.1.4. Protein Free
13.2.1.5. Serum Free
13.2.1.6. Specialty Media
13.2.2. Sera
13.2.2.1. Fetal Bovine
13.2.2.2. Newborn Calf
13.2.2.3. Others
13.2.3. Reagents
13.2.3.1. Albumin
13.2.3.1.1. Human Serum Albumin
13.2.3.1.2. Bovine Serum Albumin
13.2.3.1.3. Recombinant Serum Albumin
13.2.3.2. Amino Acids
13.2.3.3. Attached Factors
13.2.3.4. Growth Factors & Cytokines
13.2.3.4.1. Transforming Growth Factor ß1
13.2.3.4.2. Epidermal Growth Factor
13.2.3.4.3. Interleukins & Interferons
13.2.3.4.4. Others
13.2.3.5. Protease Inhibitors
13.2.3.6. Thrombin
13.2.3.7. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Biotechnology & Pharmaceutical Companies
13.3.2. Academic & Research Institutes
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of MEA
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Company Profiles
14.2.1. Thermo Fisher Scientific, Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Strategic Overview
14.2.2. Merck KGaA
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Product Portfolio
14.2.2.3. SWOT Analysis
14.2.2.4. Strategic Overview
14.2.3. Cytiva (Danaher Corporation)
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Product Portfolio
14.2.3.3. SWOT Analysis
14.2.3.4. Strategic Overview
14.2.4. Becton, Dickinson and Company
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Product Portfolio
14.2.4.3. SWOT Analysis
14.2.4.4. Strategic Overview
14.2.5. Corning Incorporated
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Product Portfolio
14.2.5.3. SWOT Analysis
14.2.5.4. Strategic Overview
14.2.6. HiMedia Laboratories
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Product Portfolio
14.2.6.3. SWOT Analysis
14.2.6.4. Strategic Overview
14.2.7. FUJIFILM Irvine Scientific, Inc.
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Product Portfolio
14.2.7.3. SWOT Analysis
14.2.7.4. Strategic Overview
14.2.8. InvivoGen
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Product Portfolio
14.2.8.3. SWOT Analysis
14.2.8.4. Strategic Overview
14.2.9. SeraCare (LGC Clinical Diagnostics, Inc.)
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Product Portfolio
14.2.9.3. SWOT Analysis
14.2.9.4. Strategic Overview
14.2.10. Lonza
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Product Portfolio
14.2.10.3. SWOT Analysis
14.2.10.4. Strategic Overview
List of Table
Table 01: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031
Table 03: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031
Table 04: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031
Table 05: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031
Table 06: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031
Table 07: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
Table 08: Global Cell Culture Media, Sera and Reagents Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 09: North America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031
Table 10: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031
Table 11: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031
Table 12: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031
Table 13: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031
Table 14: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031
Table 15: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031
Table 16: North America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Europe Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031
Table 19: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031
Table 20: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031
Table 21: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031
Table 22: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031
Table 23: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031
Table 24: Europe Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Asia Pacific Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031
Table 27: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031
Table 28: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031
Table 29: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031
Table 30: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031
Table 31: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031
Table 32: Asia Pacific Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
Table 33: Latin America Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 34: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031
Table 35: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031
Table 36: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031
Table 37: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031
Table 38: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031
Table 39: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031
Table 40: Latin America Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
Table 41: Middle East & Africa Cell Culture Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 42: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Product, 2017–2031
Table 43: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Media, 2017–2031
Table 44: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Sera, 2017–2031
Table 45: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Reagents, 2017–2031
Table 46: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Albumin, 2017–2031
Table 47: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by Growth Factors & Cytokines, 2017–2031
Table 48: Middle East & Africa Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Cell Culture Media, Sera and Reagents Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Cell Culture Media, Sera and Reagents Market Value Share, by Region, 2020
Figure 03: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031
Figure 04: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Media, 2017–2031
Figure 05: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Sera, 2017–2031
Figure 06: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Sera, 2017–2031
Figure 07: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031
Figure 08: Global Cell Culture Media, Sera, and Reagents Market, by End-user, 2021–2031
Figure 09: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Biotechnology & Pharmaceutical Companies, 2017–2031
Figure 10: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Academic & Research Institutes, 2017–2031
Figure 11: Global Cell Culture Media, Sera and Reagents Market Revenue (US$ Mn), by Others, 2017–2031
Figure 12: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 13: Global Cell Culture Media, Sera, and Reagents Market Value Share Analysis, by Region, 2020 and 2031
Figure 14: Global Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Region, 2021–2031
Figure 15: North America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 16: North America Cell Culture Media, Sera and Reagents Market Analysis Value Share Analysis, by Country, 2020 and 2031
Figure 17: North America Cell Culture Media, Sera and Reagents Market Analysis Attractiveness Analysis, by Country 2021–2031
Figure 18: North America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
Figure 19: North America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031
Figure 20: North America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 21: North America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 22: Europe Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 23: Europe Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 24: Europe Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 25: Europe Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
Figure 26: Europe Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031
Figure 27: Europe Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 28: Europe Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 29: Asia Pacific Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 30: Asia Pacific Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 31: Asia Pacific Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 32: Asia Pacific Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
Figure 33: Asia Pacific Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031
Figure 34: Asia Pacific Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 35: Asia Pacific Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 36: Latin America Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 37: Latin America Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 38: Latin America Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 39: Latin America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
Figure 40: Latin America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031
Figure 41: Latin America Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 42: Latin America Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031
Figure 43: Middle East & Africa Cell Culture Media, Sera and Reagents Market Analysis Value (US$ Mn) Forecast, 2017–2031
Figure 44: Middle East & Africa Cell Culture Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031
Figure 45: Middle East & Africa Cell Culture Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 46: Middle East & Africa Cell Culture Media, Sera and Reagents Market Value Share Analysis, by Product, 2020 and 2031
Figure 47: Middle East & Africa Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by Product, 2021–2031
Figure 48: Middle East & Africa Cell Culture Media, Sera and Reagents Market Value Share Analysis, by End-user, 2020 and 2031
Figure 49: Middle East & Africa Cell Culture Media, Sera and Reagents Market Attractiveness Analysis, by End-user, 2021–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Cell Culture Media, Sera, and Reagents Market
